My ten largest holdings right now: CAMT, ABCD, INTT, BASI, MEIP, ULBI, ATTO, VVUS, FNJN, NHLD.
CAGR since 1/1/2016: 57%. One-year return: 80%.
June 5, 2017
A lot of investors avoid microcaps. They’re hard to trade, their prices are volatile, slippage and market impact present major headaches, and there’s just not enough information out there about them to enable investors to easily judge their worth.
I love microcaps. Here are the seven reasons why.
So here are my favorite microcaps at the moment: MEI Pharma (MEIP), an oncology company; Finjan Holdings (FNJN), a cybersecurity company; YuMe (YUME), which provides digital video advertising solutions; Vivus (VVUS), a wide-ranging small biotech firm; Taseko Mines (TGB), which digs for copper, gold, and other metals; and InTest (INTT), which makes products for testing integrated circuits. All of them reported strong earnings growth last quarter compared to the same quarter last year; and in terms of value, all of them have high ratios of EPS to price and unlevered free cash flow to enterprise value, two of my key value metrics.
My ten largest holdings right now: CAMT, ABCD, INTT, BASI, MEIP, ULBI, ATTO, VVUS, FNJN, NHLD.
CAGR since 1/1/2016: 57%. One-year return: 80%.